Nyrada Inc. NYR.AX Stock
Nyrada Inc. Price Chart
Nyrada Inc. NYR.AX Financial and Trading Overview
| Nyrada Inc. stock price | 0.11 AUD |
| Previous Close | 0.08 AUD |
| Open | 0.08 AUD |
| Bid | 0.08 AUD x N/A |
| Ask | 0.09 AUD x N/A |
| Day's Range | 0.08 - 0.08 AUD |
| 52 Week Range | 0.08 - 0.18 AUD |
| Volume | 12.98K AUD |
| Avg. Volume | 76.79K AUD |
| Market Cap | 12.32M AUD |
| Beta (5Y Monthly) | 1.269938 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.03 AUD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NYR.AX Valuation Measures
| Enterprise Value | 2.98M AUD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 6.027361 |
| Price/Book (mrq) | 1.338983 |
| Enterprise Value/Revenue | 1.458 |
| Enterprise Value/EBITDA | -0.78 |
Trading Information
Nyrada Inc. Stock Price History
| Beta (5Y Monthly) | 1.269938 |
| 52-Week Change | -43.57% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.18 AUD |
| 52 Week Low | 0.08 AUD |
| 50-Day Moving Average | 0.09 AUD |
| 200-Day Moving Average | 0.12 AUD |
NYR.AX Share Statistics
| Avg. Volume (3 month) | 76.79K AUD |
| Avg. Daily Volume (10-Days) | 22.8K AUD |
| Shares Outstanding | 156.01M |
| Float | 90.31M |
| Short Ratio | N/A |
| % Held by Insiders | 42.62% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | -187.020% |
| Operating Margin (ttm) | -187.14% |
| Gross Margin | -41.86% |
| EBITDA Margin | -186.82% |
Management Effectiveness
| Return on Assets (ttm) | -20.67% |
| Return on Equity (ttm) | -35.69% |
Income Statement
| Revenue (ttm) | 2.04M AUD |
| Revenue Per Share (ttm) | 0.01 AUD |
| Quarterly Revenue Growth (yoy) | 21683.79% |
| Gross Profit (ttm) | -741328 AUD |
| EBITDA | -3820080 AUD |
| Net Income Avi to Common (ttm) | -3824171 AUD |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.34M AUD |
| Total Cash Per Share (mrq) | 0.06 AUD |
| Total Debt (mrq) | 0 AUD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 8.898 |
| Book Value Per Share (mrq) | 0.059 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1991734 AUD |
| Levered Free Cash Flow (ttm) | -376573 AUD |
Profile of Nyrada Inc.
| Country | Australia |
| State | NSW |
| City | Gordon |
| Address | 828 Pacific Highway |
| ZIP | 2072 |
| Phone | 61 2 9498 3390 |
| Website | https://www.nyrada.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular, neurodegenerative, and chronic inflammatory diseases. Its products in the drug development stage include PCSK9 inhibitor for the treatment of high blood LDL-cholesterol levels in patients poorly responsive to or unable to take statin drugs; a neuroprotectant drug to reduce the disability in patients with ischaemic stroke and traumatic brain injury; a drug to treat pain associated with peripheral nerve damage; and a drug to treat autoimmune diseases, such as psoriasis. The company has collaboration with Walter Reed Army Institute of Research and University of New South Wales, Sydney. Nyrada Inc. was incorporated in 2017 and is based in Gordon, Australia.
Q&A For Nyrada Inc. Stock
What is a current NYR.AX stock price?
Nyrada Inc. NYR.AX stock price today per share is 0.11 AUD.
How to purchase Nyrada Inc. stock?
You can buy NYR.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nyrada Inc.?
The stock symbol or ticker of Nyrada Inc. is NYR.AX.
Which industry does the Nyrada Inc. company belong to?
The Nyrada Inc. industry is Biotechnology.
How many shares does Nyrada Inc. have in circulation?
The max supply of Nyrada Inc. shares is 179.41M.
What is Nyrada Inc. Price to Earnings Ratio (PE Ratio)?
Nyrada Inc. PE Ratio is now.
What was Nyrada Inc. earnings per share over the trailing 12 months (TTM)?
Nyrada Inc. EPS is -0.03 AUD over the trailing 12 months.
Which sector does the Nyrada Inc. company belong to?
The Nyrada Inc. sector is Healthcare.